跳至主要内容
临床试验/ISRCTN99472145
ISRCTN99472145已完成未知

High blood pressure control and lipid lowering in patients at high cardiovascular risk: a cluster randomised factorial comparison of educational and protocol-based interventions to help primary care teams improve control of patients with poor risk factor control

William Harvey Research Institute (UK)0 个研究点目标入组 10,000 人开始时间: 2010年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Elevated systolic blood pressure greater than or equal to 160 mmHg within the last 12 months
  • 2. Elevated total cholesterol greater than or equal to 5 mmol/l
  • 3. Patients in secondary prevention, or risk equivalent, or hypertensives in primary prevention at more than 20% 10-year cardiovascular disease (CVD) risk by QRISK2 or Framingham equations
  • 4. Male and female, lower age limit of 40 years

排除标准

  • Compelling reasons to avoid increase in blood pressure or lipid-lowering medication, such as severe debilitating illness or terminal cancer

研究者

发起方
William Harvey Research Institute (UK)

相似试验